BACKGROUND: Symptoms of urinary incontinence are commonly perceived to vary over time; yet, there is limited quantitative evidence regarding the natural history of urinary incontinence, especially over the long term. OBJECTIVE: We sought to delineate the course of urinary incontinence symptoms over time, using 2 large cohorts of middle-aged and older women, with data collected over 10 years. STUDY DESIGN: We studied 9376 women from the Nurses' Health Study, age 56e81 years at baseline, and 7491 women from the Nurses' Health Study II, age 39e56 years, with incident urinary incontinence in 2002 through 2003. Urinary incontinence severity was measured by the Sandvik severity index. We tracked persistence, progression, remission, and improvement of symptoms over 10 years. We also examined risk factors for urinary incontinence progression using logistic regression models. RESULTS: Among women age 39e56 years, 39% had slight, 45% had moderate, and 17% had severe urinary incontinence at onset. Among women age 56e81 years, 34% had slight, 45% had moderate, and 21% had severe urinary incontinence at onset. Across ages, most women reported persistence or progression of symptoms over follow-up; few (3e11%) reported remission. However, younger women and women with less severe urinary incontinence at onset were more likely to report remission or improvement of symptoms. We found that increasing age was associated with higher odds of progression only among older women (age 75e81 vs 56e60 years; odds ratio, 1.84; 95% confidence interval, 1.51e2.25). Among all women, higher body mass index was strongly associated with progression (younger women: odds ratio, 2.37; 95% confidence interval, 2.00e2.81; body mass index !30 vs <25 kg/m 2 ; older women: odds ratio, 1.93; 95% confidence interval, 1.62e2.22). Additionally, greater physical activity was associated with lower odds of progression to severe urinary incontinence (younger women: odds ratio, 0.86; 95% confidence interval, 0.71e1.03; highest vs lowest quartile of activity; older women: odds ratio, 0.68; 95% confidence interval, 0.59e0.80). CONCLUSION: Most women with incident urinary incontinence continued to experience symptoms over 10 years; few had complete remission. Identification of risk factors for urinary incontinence progression, such as body mass index and physical activity, could be important for reducing symptoms over time.
Introduction
Urinary incontinence (UI) is a common health condition in women that adversely impacts perceived health 1 and is strongly associated with depression and social isolation. [2] [3] [4] [5] A review of several epidemiologic studies estimated up to 40% prevalence of UI in older women living in the community. [6] [7] [8] While UI is commonly perceived as a dynamic condition with symptoms that vary over time, there is limited quantitative evidence regarding the natural history of UI in patients, especially over the long term. 9 There are large prospective cohorts that have examined urinary symptoms in women over many years (ie, at least 6e10 years [10] [11] [12] [13] [14] [15] [16] [17] ) and the age range of the women studied has been limited, which may restrict generalizability of these findings. Therefore, it is difficult for clinicians to discuss with patients the likely course of their incontinence, and for clinicians and patients to appropriately consider treatment options. Thus, to provide data on the natural history of UI, we utilized data from the Nurses' Health Study (NHS) I and II, 2 large prospective cohorts of middle-aged and older women, with repeated measures of UI.
Our objective was to delineate the natural course of symptoms in women with incident UI followed up over 10 years. More specifically, our goal was to better understand whether symptoms of new UI persist, progress, improve, or remit, and whether age at onset, initial UI severity, and other risk factors influence the course of symptoms, and finally, risk factors for UI progression.
Materials and Methods

Study population
The NHS was initiated in 1976 when 121,700 female registered nurses ages 30e55 years responded to a mailed questionnaire about their medical history and lifestyle. Using similar methodology, the NHS II was initiated in 1989. The target population included women between 25e42 years old; the upper age was selected to correspond with the lowest age in NHS. A total of 116,430 women were enrolled in NHS II. Both cohorts utilize identical methods for data collection and follow-up, including biennial mailed questionnaires to update health and lifestyle information. During each questionnaire cycle, full-length questionnaires are sent in initial mailings, followed by abbreviated questionnaires to maximize participation. To date, the follow-up rate in 
Urinary incontinence
To obtain information on UI, women were asked, "During the past 12 months, how often have you leaked or lost control of your urine?" Response choices were: never, <1/mo, 1/mo, 2e3/mo, approximately 1/wk, and almost every day. Women reporting any UI were then asked, "When you lose your urine, how much usually leaks?" Response options were a few drops, enough to wet your underwear, enough to wet your outer clothing, and enough to wet the floor. A reliability study among a subgroup of these nurses demonstrated high reproducibility of responses to these questions. 18 UI severity was measured by the Sandvik severity index, using the 2 questions described above. The Sandvik index is well validated. 19 We calculated severity by multiplying the reported frequency of UI by the amount of leakage. 19 Frequency of UI was assigned a value from 1-4, with both <1/mo and 1/mo assigned a score of 1, and subsequently higher numbers indicating greater frequency. The amount of leakage was assigned a value of 1 for drops or 2 for more than drops. After multiplying scores for frequency and amount, women with a total score of 1e2 were classified as having slight UI severity, those with a score of 3-4 were classified as having moderate UI severity, and those with a score of !6 were classified as having severe UI.
For "Persistence" was defined as reporting the same severity of UI at onset and at !2 subsequent follow-up points (ie, the majority of follow-up points). "Progression" was defined as reporting a worse severity of UI at !2 follow-up points after onset. "Remission" was defined as reporting no UI at !2 followup points, and "improvement" was defined as either reporting no UI or less severe UI at !2 follow-up points than at onset. A small group of participants had patterns that did not conform to any of these definitions, and were classified as having "inconsistent patterns" of UI. Since we had many years of follow-up, and multiple repeated measures of UI, there was some overall variability in the patterns; thus, to help broadly interpret patterns and summarize the data collected, we chose to define these natural history categories based on participants' reports at the majority of follow-up points.
Measurement of risk factors
To examine risk factors for UI progression, we used information from the cohort questionnaires in 2002 (NHS) and 2003 (NHS II) on a wide variety of demographic, health, and lifestyle factors, including age, race, height and weight, reproductive history, smoking, physical activity, exogenous hormone use, history of vascular conditions, and hysterectomy. Information on physical activity was collected from NHS participants in 2000 and from NHS II participants in 2001, thus we used these reports; women reported the number of hours spent on various leisure activities (eg, walking, running) during the past year, and total energy expenditure was calculated in metabolic-equivalent task hours per week, which has been previously described in detail. 20 In addition, women reported a history of diagnoses of stroke, myocardial infarction, and type 2 diabetes.
Population for analysis
Of the original 121,700 NHS participants, 79,391 were alive and responded to UI questions on the 2002 long questionnaire. Since our focus here is new UI in 2002, we excluded women who did not have UI symptoms in 2002 and further excluded women who had UI in 2000. We included the 9376 women who provided UI information on at least 2 additional questionnaires during the period from 2004 through 2012. For 1232 of these women only missing UI data on 1 questionnaire during followup, we carried forward their reports from the previous questionnaire (after testing that the large majority of women with complete data had similar reports on consecutive questionnaires) (Figure) .
Of the original 116,430 NHS II participants, 83,006 were alive at baseline for these UI analyses and responded to UI questions on the 2003 long AJOG at a Glance Why was this study conducted? Symptoms of urinary incontinence are commonly perceived to vary over time; yet, there is limited quantitative evidence regarding the natural history of urinary incontinence, especially over the long term. We sought to delineate the course of urinary incontinence symptoms over time, using 2 large cohorts of middle-aged and older women, with data collected over 10 years.
Key findings
Most women with incident urinary incontinence continued to experience symptoms over 10 years and few women had complete remission of symptoms.
What does this add to what is known?
Identification of risk factors for urinary incontinence progression, such as body mass index and physical activity, could be important for reducing symptoms over time.
ajog.org Figure) . To test the impact of carrying forward reports for women with missing values, we also conducted analyses only including women with no missing data; since findings were extremely similar, we present all results carrying forward data if relevant.
Statistical analysis
Descriptive statistics (mean, SD, or percentage) were used to evaluate women's baseline demographic and health characteristics, after standardizing to the age distribution in each cohort.
To evaluate risk factors related to progression of UI, we used multivariable-adjusted logistic regression models to estimate odds ratios (OR) of progression from slight or moderate UI to severe UI symptoms, separately in each cohort. We considered the following variables, based on the literature regarding risk factors for UI incidence: age, race, body mass index (BMI), parity, smoking, physical activity, postmenopausal hormone use, history of vascular disease, history of type 2 diabetes, and prior hysterectomy. The status of these factors was determined based on the participants' report in 2002 for NHS and 2003 for NHS II, when UI symptoms were first reported. We performed analyses both with and without adjusting for baseline Sandvik severity index score in the multivariable-adjusted logistic regression models, since UI severity could be related to both these risk factors and to likelihood of UI progression; effect estimates for risk factors did not meaningfully differ between models and thus we report results without adjusting for baseline Sandvik severity index score. We calculated 95% confidence interval (CI) for all estimates, and evaluated linear tests of trend for ordinal variables. In addition, in secondary analyses, to evaluate risk factors that predict remission of UI symptoms, we used identical methods as those described above to estimate ORs of remission to no UI, separately in each cohort among all women with incident UI at baseline.
Results
Among women with incident UI, age 39-56 years (from NHS II), 39% had slight, 45% had moderate, and 17% had severe UI at onset. Among women with incident UI, age 56-81 years (from NHS), 34% had slight, 45% had moderate, and 21% had severe UI. Table 1 presents age-adjusted characteristics of these participants at UI onset. Among the younger women, those with severe UI compared to those with slight or moderate UI had worse health profiles; they had higher BMI, were somewhat more likely to be current smokers, had higher prevalence of type 2 diabetes, and were more likely to have had a prior hysterectomy. Among the older women, those with severe UI at onset also had higher BMI and were somewhat more likely to be current smokers, as well as to have lower physical activity levels and higher prevalence of type 2 diabetes; they also had greater prevalence of prior hysterectomy compared to older women with slight or moderate UI.
When we examined UI symptoms over 10 years (Table 2 ), overall patterns were fairly similar for both younger and older participants. Among younger women with slight UI, 81% reported continued symptomseeither persistence of slight symptoms or progression to moderate or severe UI at the majority of follow-up points, although symptoms remained slight for the majority (62%) of younger women and very few progressed to severe UI (4%). Among older women, 83% of those with slight UI at onset reported some UI over the 10-year follow-up period; 61% had persistence of slight UI symptoms, while 6% progressed to severe UI.
Among the younger women whose initial UI was moderate, 41% had persistence of moderate UI or progression to severe UI. The majority (52%) of younger women with moderate UI had remission or improvement of their UI symptoms over 10 years; however, it is notable that only 9% reported complete remissionethat is, among younger women with new onset of moderate UI symptoms, 91% still had some continuing symptoms during follow-up. Among the older women whose initial UI was moderate, 29% had persistence of moderate UI and 17% reported progression to severe UI. Fewer (45%) older women with moderate UI had remission or improvement, with only 5% reporting complete Among younger women whose incident UI was severe, 44% had persistently severe symptoms over follow-up and slightly over half reported remission or improvement of their symptoms; only 4% had complete symptom remission, such that, in total 96% continued to report some level of UI during followup. Among older women with incident, severe UI symptoms, 48% continued to have severe UI during follow-up, and slightly over half reported remission or improvement of their symptoms. Only 3% had complete symptom remission, with a total of 97% who continued to report some level of UI during followup.
Overall, although UI severity over time was somewhat variable, UI symptoms persisted during the subsequent 10 years in both younger and older women with incident UI, and worse UI at onset was indicative of higher likelihood of continued symptoms.
Risk factors for UI progression, or remission
In addition to considering the natural history of UI symptoms, we examined risk factors for UI progression from mild or moderate to severe symptoms, (Table 3) , we found that increasing age was associated with increasing odds of progression among older women, but not in younger women age. For example, among older women, those age !75 years had 1.84 times (95% CI, 1.51e2.25) the odds of progression to severe UI compared to women <60 years of age. However, when comparing the oldest to youngest age groups in the younger cohort, the OR was 1.00 (95% CI, 0.82e1.23). Increasing BMI was strongly associated with progression to severe UI symptoms in both cohorts (younger participants: OR, 2.37; 95% CI, 2.00e2.81 comparing women with BMI !30 vs <25 kg/m 2 ; older participants: OR, 1.93; 95% CI, 1.62e2.22 for the same comparison). Smoking was also related to increased odds of progression to severe UI; for example, among younger women, current smokers had 1.29 times (95% CI, 1.03e1.63) the odds of progression to severe UI compared to never smokers, and among older women the OR for progression to severe UI was 1.65 (95% CI, 1.32e2.03). Greater physical activity was generally associated with decreased odds of progression to severe UI (OR, 0.86; 95% CI, 0.71e1.03 comparing highest vs lowest quartile in younger women; OR, 0.68; 95% CI, 0.59e0.80 for older women). Finally, among older women, diabetes was associated with an increased risk of progression to severe UI (OR, 1.31; 95% CI, 1.11e1.55).
In additional analyses, we also examined the same risk factors in relation to remission of UI symptoms, separately in younger and older women (results not shown). We found that BMI and physical activity were significantly related to remission of UI symptoms. For example, among the younger women, those with BMI !30 kg/m 2 had lower odds of UI remission compared to women with BMI <25 kg/m 2 (OR, 0.70; 95% CI, 0.56e0.86). Similarly, higher BMI was associated with lower odds of UI remission among older women (OR, 0.71; 95% CI, 0.54e0.92). Greater physical activity was significantly association with increased odds of UI remission among younger women (OR, 1.33; 95% CI, 1.06e1.67 comparing highest vs lowest quartile) but not older women (OR, 0.94; 95% CI, 0.73e1.22).
Comment
Overall, patterns of UI symptoms over 10 years were similar for younger and older women. The vast majority of women with incident UI continue to experience UI over 10 years of follow-up, while very few (<10%) have remission of UI symptoms. Severity of UI at onset was associated with the likelihood of persistent symptoms; among women with incident severe UI, 96-97% reported continued UI symptoms during follow-up. In this study, 2 important modifiable risk factors associated with odds of UI progression to severe symptoms were identified: physical activity and BMI. Women in the lowest quartile of physical activity and women who were overweight and obese (BMI >30 kg/m 2 ) when they reported UI symptom onset had an increased odds of symptom progression over 10 years of follow-up.
The majority of prior studies regarding the natural history of UI have generally considered 2 follow-up points, [21] [22] [23] [24] [25] [26] from which it is difficult to (11) 1725 (52) 706 (56) 229 (7) 1889 (45) 1024 (52) Remission to no UI 323 (11) 286 (9) 54 (4) 229 (7) 196 (5) 64 ( Original Research GYNECOLOGY ajog.org [21] [22] [23] [24] [25] [26] In this analysis, we were able to describe patterns of persistence, progression, improvement, and remission of UI symptoms for a large sample of women with new onset of UI, over 10 years of follow-up, and over 4 data intervals.
In general, the findings from our study are consistent with prior studies that have investigated patterns of UI over time. A review of 14 longitudinal studies of UI found that symptoms reported at baseline tended to persist throughout follow-up and remission of symptoms was more likely to occur among younger women. 9 The majority of these studies only followed up participants for 1e2 years and studies with longer follow-up (9-16 years) generally only assessed symptoms at baseline and the end of follow-up.
Studies that have specifically investigated patterns of UI according to severity have found that severe UI is more common among older women 8 and that women with severe UI are less likely to experience improvement in symptoms compared to women with mild or moderate UI. 27 Overall, estimates for rates of remission of UI symptoms have varied widely (3e40%) across studies, although study designs vary also making it difficult to directly compare results. 6, 26, 27 In general, studies that reported higher rates of remission were conducted among younger women or defined remission as only 1 report of no UI symptoms. In the current analysis, we found that very few women (3e11%, depending on age and severity of incident UI) experience remission of UI symptoms at >1 time point over 10 years. Similar to prior studies, we found somewhat less remission among older women. Additionally, we had a longer follow-up with a larger sample size across a wider range of ages and more measures of UI over time in our study and thus we were likely able to better capture women who truly experience remission of symptoms vs fluctuations of UI symptoms.
Very few studies have investigated risk factors related to progression of UI symptoms and most have only looked at age. 9 In the present analysis, we considered a number of potential risk factors for UI progression and found significant associations for BMI and physical activity; for analyses of UI progression, findings were consistent among both younger and older women. With further research confirming these findings, our results indicate that both older and younger women may be able to alter their likelihood of progressing to severe incontinence by addressing BMI and physical activity, which could be important for eventually creating public health messaging for women who want to reduce the negative impact of incontinence. In the clinical setting among women with slight disease who are not yet bothered by their current symptoms, such messages may provide an avenue for reducing risk of worsening whether patients decide to undergo treatment or not.
A major strength of our study is the multiple, repeated measures of UI over time among both younger and older women. Our study also has several limitations. First, UI information was selfreported; however, we have previously demonstrated higher reliability of self-reported incontinence symptoms among these women, 18 and other studies have demonstrated high validity of selfreported incontinence compared to clinical assessment. 28 Additionally, our assessment of UI symptoms via mailed questionnaires helps to reduce embarrassment that might otherwise cause underreporting of UI among these women. Secondly, our study population is relatively homogenous, consisting of nurses who are predominantly white. While this may limit generalizability, we would expect accurate reporting of symptoms and health status in this population that strengthens the validity of our findings. Moreover, although our participants are health professionals, in previous research on UI in this cohort, we have consistently found that UI prevalence, incidence, and risk factors are similar to those in other populations, and thus findings here are likely generalizable to White women. Furthermore, there is no specific reason to suspect that UI patterns would differ among nurses vs other women. Thirdly, we only included women with new onset of UI and excluded those who had reported UI symptoms in the time period before baseline, to focus on a homogenous and clinically relevant group of women with new symptoms. However, we cannot be absolutely certain that all these incident UI cases had never previously experienced UI since we did not track symptoms for many years prior to baseline; nonetheless, since the present analysis demonstrates that very few women (<7%) have remission of UI symptoms, it is highly likely that the vast majority of UI cases included in our analytic cohort here are indeed incident. Lastly, we do not have information on UI treatment. This may suggest that we may be somewhat underestimating spontaneous remission of reduction of UI symptoms. However, in a substudy among a sample of participants with frequent UI, we inquired about UI treatments, and only 20% reported treatment, similar to other studies. In calculations to assess sensitivity of our findings, we calculated that if 20% of women who experienced remission had used treatment, the proportion of younger women with spontaneous incontinence remission would only change from 9e7% and the proportion of older women with spontaneous incontinence remission would change from 5e4%. Thus, the small number of treated women should not meaningfully alter our conclusions. Moreover, we found in our substudy of participants with frequent UI that 47% of women who received treatment reported little to no improvement in their UI symptoms. Thus, it is not likely that treatment had a significant impact on our results.
Overall, the vast majority of women with new UI symptoms continue to experience UI over 10 years, while very few have complete remission of UI symptoms. Additionally, we found patterns of UI over 10 years were similar for younger and older women. Identification of potential risk factors for prevention of UI progression, such as BMI and physical activity, could be important for reducing symptoms over time.
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